Rahul Kuver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rahul Kuver has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Sum P. Lee
Department of Medicine, Division of Gastroenterology , University of Washington School of Medicine, Seattle, WA, USA
7 shared publicationsChristopher E. Savard
4 shared publications- Nisana Namwat
Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand
2 shared publications - Puangrat Yongvanit
Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
2 shared publications Sum P Lee
The Li Ka Shing Faculty of Medicine, University of Hong Kong
2 shared publications- Sum P. Lee
Department of Medicine, University of Washington School of Medicine, the Puget Sound Veterans Affairs Health Care System, Seattle, WA
2 shared publications
Latest Publications
- Open Access
- 17 June 2016
- Published by F1000 Research Ltd in F1000Research
- Vol. 5, 1409
The changing faces of cholangitis
A variety of diseases are included under the umbrella term ‘cholangitis’, including hepatobiliary diseases with an autoimmune pathogenesis (such as primary sclerosing cholangitis, primary biliary cholangitis, and IgG4-associated sclerosing cholangitis) and disease processes associated with intraductal stones and infectious etiologies (such as ascending bacterial cholangitis, recurrent pyogenic cholangitis, and liver fluke-associated cholangitis). Recent advances in the pathophysiologic bases of these disorders, particularly with respect to the autoimmune variety, are allowing improved diagnosis and prognostication as well as providing the opportunity to refine and re-imagine treatment modalities. The aim of this review is to highlight selected advances in cholangitis research that point to novel insights into the pathophysiology, diagnosis, and treatment of this diverse array of disorders.
- 17 June 2016
- Published by F1000 Research Ltd in F1000Research
- Vol. 5, 1409
Open AccessThe changing faces of cholangitis
A variety of diseases are included under the umbrella term ‘cholangitis’, including hepatobiliary diseases with an autoimmune pathogenesis (such as primary sclerosing cholangitis, primary biliary cholangitis, and IgG4-associated sclerosing cholangitis) and disease processes associated with intraductal stones and infectious etiologies (such as ascending bacterial cholangitis, recurrent pyogenic cholangitis, and liver fluke-associated cholangitis). Recent advances in the pathophysiologic bases of these disorders, particularly with respect to the autoimmune variety, are allowing improved diagnosis and prognostication as well as providing the opportunity to refine and re-imagine treatment modalities. The aim of this review is to highlight selected advances in cholangitis research that point to novel insights into the pathophysiology, diagnosis, and treatment of this diverse array of disorders.
- 1 December 2013
- Published by Elsevier in Journal of Surgical Research
- Vol. 185 (2) , 526-7
In search of lost hepatocytes: sensory innervation, calcitonin gene-related peptide, and regeneration in the liver.
- 1 December 2013
- Published by Elsevier in Journal of Surgical Research
- Vol. 185 (2) , 526-7
In search of lost hepatocytes: sensory innervation, calcitonin gene-related peptide, and regeneration in the liver.
- 1 June 2013
- Published by Elsevier in Journal of Surgical Research
- Vol. 182 (2) , 207-209
The expanding universe of bile acid physiology: Delving into the mysteries of dark (green) matter
- 1 June 2013
- Published by Elsevier in Journal of Surgical Research
- Vol. 182 (2) , 207-209
The expanding universe of bile acid physiology: Delving into the mysteries of dark (green) matter
- 1 October 2012
- Published by Taylor & Francis in Clinical Lipidology
- Vol. 7 (5) , 537-548
Mechanisms of oxysterol-induced disease: insights from the biliary system
Oxysterols are oxidized species of cholesterol that are derived from exogenous (e.g. dietary) and endogenous (in vivo) sources. Oxysterols play critical roles in normal physiologic functions as well as in pathophysiologic processes in a variety of organ systems. This review provides an overview of oxysterol biology from the vantage point of the biliary system. Several oxysterols have been identified in human bile in the context of biliary tract infection and inflammation. This finding has led to investigations regarding the potential pathophysiologic significance of biliary oxysterols in diseases affecting the biliary system, with an emphasis on cholangiocarcinoma. Emerging evidence implicates specific oxysterols in the development and progression of this malignancy. This review will summarize the literature on oxysterols in the biliary system and discuss how the accumulated evidence contributes to a hypothesis describing the molecular basis of cholangiocarcinogenesis.
- 1 October 2012
- Published by Taylor & Francis in Clinical Lipidology
- Vol. 7 (5) , 537-548
Mechanisms of oxysterol-induced disease: insights from the biliary system
Oxysterols are oxidized species of cholesterol that are derived from exogenous (e.g. dietary) and endogenous (in vivo) sources. Oxysterols play critical roles in normal physiologic functions as well as in pathophysiologic processes in a variety of organ systems. This review provides an overview of oxysterol biology from the vantage point of the biliary system. Several oxysterols have been identified in human bile in the context of biliary tract infection and inflammation. This finding has led to investigations regarding the potential pathophysiologic significance of biliary oxysterols in diseases affecting the biliary system, with an emphasis on cholangiocarcinoma. Emerging evidence implicates specific oxysterols in the development and progression of this malignancy. This review will summarize the literature on oxysterols in the biliary system and discuss how the accumulated evidence contributes to a hypothesis describing the molecular basis of cholangiocarcinogenesis.
- 1 January 2012
- p. 77-82
Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma.
Bile acids are implicated as aetiological factors in many types of gastrointestinal tract cancer including cholangiocarcinoma (CCA). Alterations in bile acid concentrations may affect the pathogenesis of these different types of cancer. Our aim was to determine the bile acid profile in gallbladder bile from patients who underwent liver resection. Thirty-seven patients with cholangiocarcinoma, 5 with hepatocellular carcinoma, and 7 with benign biliary diseases were studied. High pressure liquid chromatography was used to analyze conjugated and unconjugated bile acids. CCA patients with low (≤ 2 mg/dl) and high (>2 mg/dl) levels of total serum bilirubin had significantly higher total bile acid and conjugated bile acid concentrations than the benign biliary disease group. Markedly elevated levels of cholic and chenodeoxycholic acid were found in CCA cases with high levels of total serum bilirubin. Concentrations of total bile acids and primary bile acid were correlated with serum cholesterol, bilirubin and ALP in CCA. Notably, correlation of the carcinoembryonic antigen, a tumor marker, was found with level of total bile acids and chenodeoxycholic acid. These findings suggest a different pattern of bile acid concentration in cancer patients compared to patients with benign biliary diseases. Thus, accumulation of certain bile acids may be involved in carcinogenesis.
- 1 January 2012
- p. 77-82
Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma.
Bile acids are implicated as aetiological factors in many types of gastrointestinal tract cancer including cholangiocarcinoma (CCA). Alterations in bile acid concentrations may affect the pathogenesis of these different types of cancer. Our aim was to determine the bile acid profile in gallbladder bile from patients who underwent liver resection. Thirty-seven patients with cholangiocarcinoma, 5 with hepatocellular carcinoma, and 7 with benign biliary diseases were studied. High pressure liquid chromatography was used to analyze conjugated and unconjugated bile acids. CCA patients with low (≤ 2 mg/dl) and high (>2 mg/dl) levels of total serum bilirubin had significantly higher total bile acid and conjugated bile acid concentrations than the benign biliary disease group. Markedly elevated levels of cholic and chenodeoxycholic acid were found in CCA cases with high levels of total serum bilirubin. Concentrations of total bile acids and primary bile acid were correlated with serum cholesterol, bilirubin and ALP in CCA. Notably, correlation of the carcinoembryonic antigen, a tumor marker, was found with level of total bile acids and chenodeoxycholic acid. These findings suggest a different pattern of bile acid concentration in cancer patients compared to patients with benign biliary diseases. Thus, accumulation of certain bile acids may be involved in carcinogenesis.
- Open Access
- 22 September 2011
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 26 (10) , 1467-1469
Effects of statins on cholestasis: Good, bad or indifferent?
See article in J. Gastroenterol. Hepatol. 2011; 26: 1544–1551.
- 22 September 2011
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 26 (10) , 1467-1469
Open AccessEffects of statins on cholestasis: Good, bad or indifferent?
See article in J. Gastroenterol. Hepatol. 2011; 26: 1544–1551.
- Open Access
- 9 March 2011
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 10 (1) , 44
Mechanisms of oxysterol-induced carcinogenesis
Oxysterols are oxidation products of cholesterol that are generated by enzymatic reactions mediated by cytochrome P450 family enzymes or by non-enzymatic reactions involving reactive oxygen and nitrogen species. Oxysterols play various regulatory roles in normal cellular processes such as cholesterol homeostasis by acting as intermediates in cholesterol catabolism. Pathological effects of oxysterols have also been described, and various reports have implicated oxysterols in several disease states, including atherosclerosis, neurological disease, and cancer. Numerous studies show that oxysterols are associated with various types of cancer, including cancers of the colon, lung, skin, breast and bile ducts. The molecular mechanisms whereby oxysterols contribute to the initiation and progression of cancer are an area of active investigation. This review focuses on the current state of knowledge regarding the role of oxysterols in carcinogenesis. Mutagenicity of oxysterols has been described in both nuclear and mitochondrial DNA. Certain oxysterols such as cholesterol-epoxide and cholestanetriol have been shown to be mutagenic and genotoxic. Oxysterols possess pro-oxidative and pro-inflammatory properties that can contribute to carcinogenesis. Oxysterols can induce the production of inflammatory cytokines such as interleukin-8 and interleukin-1β. Certain oxysterols are also involved in the induction of cyclo-oxygenase-2 expression. Inflammatory effects can also be mediated through the activation of liver-X-receptor, a nuclear receptor for oxysterols. Thus, several distinct molecular mechanisms have been described showing that oxysterols contribute to the initiation and progression of cancers arising in various organ systems.
- 9 March 2011
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 10 (1) , 44
Open AccessMechanisms of oxysterol-induced carcinogenesis
Oxysterols are oxidation products of cholesterol that are generated by enzymatic reactions mediated by cytochrome P450 family enzymes or by non-enzymatic reactions involving reactive oxygen and nitrogen species. Oxysterols play various regulatory roles in normal cellular processes such as cholesterol homeostasis by acting as intermediates in cholesterol catabolism. Pathological effects of oxysterols have also been described, and various reports have implicated oxysterols in several disease states, including atherosclerosis, neurological disease, and cancer. Numerous studies show that oxysterols are associated with various types of cancer, including cancers of the colon, lung, skin, breast and bile ducts. The molecular mechanisms whereby oxysterols contribute to the initiation and progression of cancer are an area of active investigation. This review focuses on the current state of knowledge regarding the role of oxysterols in carcinogenesis. Mutagenicity of oxysterols has been described in both nuclear and mitochondrial DNA. Certain oxysterols such as cholesterol-epoxide and cholestanetriol have been shown to be mutagenic and genotoxic. Oxysterols possess pro-oxidative and pro-inflammatory properties that can contribute to carcinogenesis. Oxysterols can induce the production of inflammatory cytokines such as interleukin-8 and interleukin-1β. Certain oxysterols are also involved in the induction of cyclo-oxygenase-2 expression. Inflammatory effects can also be mediated through the activation of liver-X-receptor, a nuclear receptor for oxysterols. Thus, several distinct molecular mechanisms have been described showing that oxysterols contribute to the initiation and progression of cancers arising in various organ systems.
- 26 May 2010
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 25 (6) , 1020-1023
Bioactive sphingolipids in the biliary tract: Relevance for cholesterol gallstone disease
- 26 May 2010
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 25 (6) , 1020-1023
Bioactive sphingolipids in the biliary tract: Relevance for cholesterol gallstone disease
- 29 July 2009
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 24 (7) , 1218-1225
Effects of lipopolysaccharide on platelet‐derived growth factor isoform and receptor expression in cultured rat common bile duct fibroblasts and cholangiocytes
Background and Aim: Little is known about the role of platelet‐derived growth factor (PDGF) in biliary fibrosis in the setting of bacterial colonization of the biliary tree. We therefore sought to investigate whether exposure to bacterial lipopolysaccharide (LPS) alters PDGF isoform and receptor expression in cultured rat common bile duct fibroblasts (CBDF) and normal rat cholangiocytes (NRC).Methods: Collagen content in cells and media was assessed by colorimetric assay and gel electrophoresis. mRNA levels of PDGF‐A and ‐B, and PDGF‐Receptors (PDGF‐R) α and β were measured by relative quantitative real‐time PCR. Protein levels of PDGF‐AA, AB and BB were measured by ELISA, and PDGF‐Rα and PDGF‐Rβ by Western blot.Results: In CBDF, LPS increased total soluble collagen synthesis and secretion. PDGF‐Rα and β mRNA and protein were also increased by LPS treatment in CBDF. Lipopolysaccharide treatment elicited an increase in PDGF‐A and ‐B mRNA levels in CBDF. In NRC, levels of PDGF‐A mRNA increased in a dose‐dependent fashion following LPS treatment, whereas PDGF‐B mRNA showed no response. PDGF‐AA secretion was higher by CBDF than by NRC. PDGF‐BB levels were also higher in CBDF than in NRC. While PDGF‐BB levels did not respond to LPS treatment in CBDF, there was a dose‐dependent response of this isoform to LPS in NRC. Intracellular and secreted PDGF‐AB increased with LPS treatment in NRC.Conclusions: These results support a model in which chronic bacterial colonization of the biliary tree induces fibrosis through PDGF‐dependent mechanisms.
- 29 July 2009
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 24 (7) , 1218-1225
Effects of lipopolysaccharide on platelet‐derived growth factor isoform and receptor expression in cultured rat common bile duct fibroblasts and cholangiocytes
Background and Aim: Little is known about the role of platelet‐derived growth factor (PDGF) in biliary fibrosis in the setting of bacterial colonization of the biliary tree. We therefore sought to investigate whether exposure to bacterial lipopolysaccharide (LPS) alters PDGF isoform and receptor expression in cultured rat common bile duct fibroblasts (CBDF) and normal rat cholangiocytes (NRC).Methods: Collagen content in cells and media was assessed by colorimetric assay and gel electrophoresis. mRNA levels of PDGF‐A and ‐B, and PDGF‐Receptors (PDGF‐R) α and β were measured by relative quantitative real‐time PCR. Protein levels of PDGF‐AA, AB and BB were measured by ELISA, and PDGF‐Rα and PDGF‐Rβ by Western blot.Results: In CBDF, LPS increased total soluble collagen synthesis and secretion. PDGF‐Rα and β mRNA and protein were also increased by LPS treatment in CBDF. Lipopolysaccharide treatment elicited an increase in PDGF‐A and ‐B mRNA levels in CBDF. In NRC, levels of PDGF‐A mRNA increased in a dose‐dependent fashion following LPS treatment, whereas PDGF‐B mRNA showed no response. PDGF‐AA secretion was higher by CBDF than by NRC. PDGF‐BB levels were also higher in CBDF than in NRC. While PDGF‐BB levels did not respond to LPS treatment in CBDF, there was a dose‐dependent response of this isoform to LPS in NRC. Intracellular and secreted PDGF‐AB increased with LPS treatment in NRC.Conclusions: These results support a model in which chronic bacterial colonization of the biliary tree induces fibrosis through PDGF‐dependent mechanisms.
- 31 March 2009
- Published by Elsevier in The American Journal of Pathology
- Vol. 174 (3) , 842-853
Gallbladder Epithelial Cells that Engraft in Mouse Liver Can Differentiate into Hepatocyte-Like Cells
- 31 March 2009
- Published by Elsevier in The American Journal of Pathology
- Vol. 174 (3) , 842-853
Gallbladder Epithelial Cells that Engraft in Mouse Liver Can Differentiate into Hepatocyte-Like Cells